These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30115425)

  • 21. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.
    Drawz PE; Pajewski NM; Bates JT; Bello NA; Cushman WC; Dwyer JP; Fine LJ; Goff DC; Haley WE; Krousel-Wood M; McWilliams A; Rifkin DE; Slinin Y; Taylor A; Townsend R; Wall B; Wright JT; Rahman M
    Hypertension; 2017 Jan; 69(1):42-50. PubMed ID: 27849563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Intensive Blood Pressure Control in Patients with Evident Cardiovascular Disease: An Investigation Using the SPRINT Study Data.
    Vlachopoulos C; Terentes-Printzios D; Aznaouridis K; Ioakeimidis N; Xaplanteris P; Lazaros G; Tousoulis D
    Curr Vasc Pharmacol; 2019; 17(3):298-306. PubMed ID: 29512468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex Differences of Patients With Systemic Hypertension (From the Analysis of the Systolic Blood Pressure Intervention Trial [SPRINT]).
    Ochoa-Jimenez R; Viquez-Beita K; Daluwatte C; Zusterzeel R
    Am J Cardiol; 2018 Sep; 122(6):985-993. PubMed ID: 30072129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
    JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.
    Myers MG; Kaczorowski J; Dolovich L; Tu K; Paterson JM
    Hypertension; 2016 Oct; 68(4):866-72. PubMed ID: 27528062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control].
    Widimský J
    Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
    Huang C; Dhruva SS; Coppi AC; Warner F; Li SX; Lin H; Nasir K; Krumholz HM
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29133522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors.
    Whelton SP; McEvoy JW; Shaw L; Psaty BM; Lima JAC; Budoff M; Nasir K; Szklo M; Blumenthal RS; Blaha MJ
    JAMA Cardiol; 2020 Sep; 5(9):1011-1018. PubMed ID: 32936272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of intensive blood pressure treatment and non-fatal cardiovascular or serious adverse events in older adults with mortality: mediation analysis in SPRINT.
    Krishnaswami A; Rich MW; Kwak MJ; Goyal P; Forman DE; Damluji AA; Solomon M; Rana JS; Kado DM; Odden MC
    Eur J Prev Cardiol; 2023 Aug; 30(10):996-1004. PubMed ID: 37185634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension.
    Phillips RA; Xu J; Peterson LE; Arnold RM; Diamond JA; Schussheim AE
    J Am Coll Cardiol; 2018 Apr; 71(15):1601-1610. PubMed ID: 29525494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of Hypertension Management Strategies in SPRINT-Eligible US Adults: A Simulation Study.
    Zhang F; Bryant KB; Moran AE; Zhang Y; Cohen JB; Bress AP; Sheppard JP; King JB; Derington CG; Weintraub WS; Kronish IM; Shea S; Bellows BK
    J Am Heart Assoc; 2024 Jan; 13(2):e032370. PubMed ID: 38214272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations.
    Ko MJ; Jo AJ; Park CM; Kim HJ; Kim YJ; Park DW
    J Am Coll Cardiol; 2016 Jun; 67(24):2821-31. PubMed ID: 27311520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should blood pressure goal be individualized in hypertensive patients?
    Yannoutsos A; Kheder-Elfekih R; Halimi JM; Safar ME; Blacher J
    Pharmacol Res; 2017 Apr; 118():53-63. PubMed ID: 27919826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline blood pressure control in Hispanics: characteristics of Hispanics in the Systolic Blood Pressure Intervention Trial.
    Rodriguez CJ; Still CH; Garcia KR; Wagenknecht L; White S; Bates JT; Del Cid MV; Lioudis M; Lopez Barrera N; Moreyra A; Punzi H; Ringer RJ; Cushman WC; Contreras G; Servilla K; Rocco M;
    J Clin Hypertens (Greenwich); 2017 Feb; 19(2):116-125. PubMed ID: 27862904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can Antihypertensive Treatment Restore the Risk of Cardiovascular Disease to Ideal Levels?: The Coronary Artery Risk Development in Young Adults (CARDIA) Study and the Multi-Ethnic Study of Atherosclerosis (MESA).
    Liu K; Colangelo LA; Daviglus ML; Goff DC; Pletcher M; Schreiner PJ; Sibley CT; Burke GL; Post WS; Michos ED; Lloyd-Jones DM
    J Am Heart Assoc; 2015 Sep; 4(9):e002275. PubMed ID: 26391135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applicability of the Systolic Blood Pressure Intervention Trial (SPRINT) to the Canadian Population.
    Leung AA; Chang HJ; McAlister FA; Khan NA; Rabi DM; Quan H; Padwal RS
    Can J Cardiol; 2018 May; 34(5):670-675. PubMed ID: 29731026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive blood pressure treatment in coronary artery disease: implications from the Systolic Blood Pressure Intervention Trial (SPRINT).
    Zang J; Liang J; Zhuang X; Zhang S; Liao X; Wu G
    J Hum Hypertens; 2022 Jan; 36(1):86-94. PubMed ID: 33589758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying Individuals at Risk for Cardiovascular Events Across the Spectrum of Blood Pressure Levels.
    Karmali KN; Ning H; Goff DC; Lloyd-Jones DM
    J Am Heart Assoc; 2015 Sep; 4(9):e002126. PubMed ID: 26391134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of a Simple Algorithm to Identify Hypertensive Patients Who Benefit from Intensive Blood Pressure Lowering.
    Wang S; Khera R; Das SR; Vigen R; Wang T; Luo X; Lu R; Zhan X; Xiao G; Vongpatanasin W; Xie Y
    Am J Cardiol; 2018 Jul; 122(2):248-254. PubMed ID: 29880288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between Intensive vs Standard Blood Pressure Control and Incident Left Ventricular Conduction Disease: A Post Hoc Analysis of the SPRINT Randomized Clinical Trial.
    Frimodt-Møller EK; Vittinghoff E; Kaur G; Biering-Sørensen T; Soliman EZ; Marcus GM
    JAMA Cardiol; 2023 Jun; 8(6):612-616. PubMed ID: 37133829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.